Client 1ST Advisory Group LLC Invests $312,000 in Elevance Health, Inc. (NYSE:ELV)

Client 1ST Advisory Group LLC bought a new stake in Elevance Health, Inc. (NYSE:ELV - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 846 shares of the company's stock, valued at approximately $312,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Raelipskie Partnership purchased a new stake in Elevance Health during the 3rd quarter worth approximately $26,000. PSI Advisors LLC purchased a new position in Elevance Health in the 3rd quarter worth approximately $27,000. Eastern Bank purchased a new position in Elevance Health during the third quarter worth approximately $31,000. Dunhill Financial LLC grew its holdings in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after buying an additional 26 shares in the last quarter. Finally, Peterson Financial Group Inc. purchased a new position in shares of Elevance Health during the 3rd quarter worth $44,000. Hedge funds and other institutional investors own 89.24% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on ELV shares. Mizuho decreased their target price on shares of Elevance Health from $585.00 to $505.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th. Raymond James set a $485.00 price target on Elevance Health in a research note on Friday, October 18th. TD Cowen reduced their price objective on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a report on Monday, October 21st. Stephens reissued an "underperform" rating on shares of Elevance Health in a research note on Friday, October 18th. Finally, Royal Bank of Canada lowered their price objective on shares of Elevance Health from $585.00 to $478.00 and set an "outperform" rating for the company in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Elevance Health presently has an average rating of "Moderate Buy" and a consensus price target of $536.53.

Elevance Health Stock Down 0.3 %

ELV traded down $1.00 on Monday, hitting $384.26. 2,696,400 shares of the company were exchanged, compared to its average volume of 1,457,754. The firm has a 50-day moving average price of $388.02 and a two-hundred day moving average price of $466.18. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26. The company has a market cap of $89.12 billion, a price-to-earnings ratio of 14.01, a price-to-earnings-growth ratio of 1.08 and a beta of 0.84.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The company had revenue of $44.72 billion for the quarter, compared to analyst estimates of $43.47 billion. During the same period in the prior year, the firm posted $8.99 earnings per share. The business's quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities analysts predict that Elevance Health, Inc. will post 32.96 earnings per share for the current year.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.